No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Diagnostics & Research
Vijaya Diagnostic Centre Limited delivers a broad spectrum of diagnostic services to patients across India. Its extensive laboratory offerings include clinical biochemistry, haematology (and immune-haematology), clinical pathology, histopathology, cytopathology, microbiology, serology, cytogenetics, and molecular pathology. For imaging, the company provides advanced radiology services such as magnetic resonance imaging (MRI), multi-slice CT, 3D dental CBCT, mammography, DEXA/bone densitometry, ultrasound with color doppler, nuclear medicine including PET/CT, and digital X-rays. Beyond these, specialized services cover cardiology, neurology, and gastroenterology. The center also offers health check-up packages and convenient home sample collection. Headquartered in Hyderabad, India, and founded in 1981, Vijaya Diagnostic Centre operates a significant network of 80 diagnostic centers and 11 reference laboratories. These facilities are spread across 13 cities and towns, primarily in Telangana and Andhra Pradesh, alongside the National Capital Region and Kolkata.
www.vijayadiagnostic.comNo one on the platform currently holds VIJAYA.NS.
No tracked institution reports a position in VIJAYA.NS as of their last filing.
No one on the platform has traded VIJAYA.NS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 13.6% | 14.2% | — | — | — | |
| Rev. Growth % | 19.6% | 16.7% | ||||
| Profit Margin % | 21.2% | 21.2% | ||||
| Free Cash Flow Margin % | 10.8% | 12.7% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $9.9B | +22.8% | $22.75 | $21.89–$24.29 | — | 9 |
| 2028 | $11.9B | +20.4% | $28.75 | $26.07–$31.00 | — | 9 |
| 2029 | $14.1B | +18.2% | $34.00 | $28.25–$37.31 | — | 5 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $4.54 | $5.20 | +14.5% |
| 2026-05-07 | $4.21 | $4.70 | +11.6% |
| 2026-02-13 | $3.92 | $4.20 | +7.1% |
| 2025-11-04 | $4.39 | $4.20 | -4.3% |
| 2025-07-28 | $3.45 | $3.73 | +8.1% |
| 2025-05-12 | $3.73 | $3.45 | -7.5% |
| 2025-02-12 | $3.50 | $3.40 | -2.9% |
| 2024-11-07 | $3.80 | $4.10 | +7.9% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| VIJAYA.NSVijaya Diagnostic Centre Limited | $1443.70 | -3.88% | $148.6B | — |
| JLHL.BOJupiter Life Line Hospitals Limited | $275.40 | -1.27% | $91.9B | — |
| JLHL.NSJupiter Life Line Hospitals Limited | $275.55 | -1.29% | $90.3B | — |
| MEDPLUS.BOMedPlus Health Services Limited | $655.25 | -0.81% | $78.7B | — |
| MEDPLUS.NSMedPlus Health Services Limited |
| $656.30 |
| -0.58% |
| $78.8B |
| — |
| METROPOLIS.BOMetropolis Healthcare Limited | $572.30 | -2.25% | $119.1B | — |
| METROPOLIS.NSMetropolis Healthcare Limited | $572.50 | -2.22% | $118.7B | — |
Source: Financial Modeling Prep · peers by sector/industry